Lexaria Bioscience LEXX
NASDAQ LEXX
$3.15 +0.06 (+1.94%)
As of: Oct 1, 2026 · 9:32 AM EDT

Lexaria Bioscience (LEXX) Tax Provisions (2025 - 2026)

Updated

Lexaria Bioscience (LEXX) reported Tax Provisions of $14.00 for fiscal Q3 2026 (quarter ended May 31, 2026), down 99.5% from the prior quarter.

Analysis

Lexaria Bioscience (LEXX) Tax Provisions (2025 - 2026) Analysis & Trends

Over the twelve months ended May 31, 2026, Lexaria Bioscience's Tax Provisions came in at $4,403.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Taxes (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.21 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 662.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 654.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -1.01 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -291.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 393.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 242.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -407.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 292.00 Mn
10 Lexaria Bioscience 3.26 Mn -12.39 Mn - 14.00
Historic Data

Historic Data

Download Data
DateValue
May 31, 2026 14.00
Feb 28, 2026 2,598.00
Nov 30, 2025 1,791.00
API Access

Lexaria Bioscience Tax Provisions API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-provisions&ticker=LEXX&period=max&api_key=YOUR_API_KEY